Change in histone H3 phosphorylation, MAP kinase p38, SIR 2 and p53 expression by resveratrol in preventing streptozotocin induced type I diabetic nephropathy.
about
Autophagy in Chronic Kidney DiseasesHistone Acetylation and Its Modifiers in the Pathogenesis of Diabetic NephropathyRole of nutrient-sensing signals in the pathogenesis of diabetic nephropathyCellular and molecular effects of resveratrol in health and diseaseRosiglitazone synergizes anticancer activity of cisplatin and reduces its nephrotoxicity in 7, 12-dimethyl benz{a}anthracene (DMBA) induced breast cancer rats.Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytesResveratrol suppresses colitis and colon cancer associated with colitis.Respected Sir(2): magic target for diabetesThe Role of SIRT1 in Diabetic Kidney Disease.Differential proteomics identifies PDIA3 as a novel chemoprevention target in human colon cancer cells.Stage-specific quantitative changes in renal and urinary proteome during the progression and development of streptozotocin-induced diabetic nephropathy in rats.Nutrient sensing, autophagy, and diabetic nephropathy.Sirtuin 1: A Target for Kidney Diseases.Resveratrol Ameliorates Diabetes-induced Renal Damage through Regulating the Expression of TGF-β1, Collagen IV and Th17/Treg-related Cytokines in Rats.Transforming growth factor-β-induced cross talk between p53 and a microRNA in the pathogenesis of diabetic nephropathyTranscription factors in the pathogenesis of diabetic nephropathy.Resveratrol Prevention of Diabetic Nephropathy Is Associated with the Suppression of Renal Inflammation and Mesangial Cell Proliferation: Possible Roles of Akt/NF-κB Pathway.Autophagy as a therapeutic target in diabetic nephropathy.Cellular and molecular mechanisms of diabetic glomerulopathy.Pathophysiology of the aging kidney and therapeutic interventions.Anti-aging molecule, Sirt1: a novel therapeutic target for diabetic nephropathy.Interventions against nutrient-sensing pathways represent an emerging new therapeutic approach for diabetic nephropathy.Renal protective effects of resveratrol.Sirtuin and metabolic kidney disease.Natural polyphenols based new therapeutic avenues for advanced biomedical applications.In vivo RNA interference models of inducible and reversible Sirt1 knockdown in kidney cells.Control of stability of cyclin D1 by quinone reductase 2 in CWR22Rv1 prostate cancer cells.Exercise test and glucose homeostasis in rats treated with alloxan during the neonatal period or fed a high calorie diet.Mitigating Effect of Resveratrol on the Structural Changes of Mice Liver and Kidney Induced by Cadmium; A Stereological Study.Upregulation of microRNA-146a was not accompanied by downregulation of pro-inflammatory markers in diabetic kidney.Theobromine increases NAD⁺/Sirt-1 activity and protects the kidney under diabetic conditions.
P2860
Q26740427-B2BF7569-C443-4536-99AB-46FE57DC0DD2Q26744442-A2B41EF7-9F4E-4737-B074-335D71B0D086Q26828026-D023BFD6-9B51-408B-9362-67705856E542Q28252560-89A2E0F1-46A9-4DB8-9DC2-6E68DBDAA9C7Q33428310-7641DBFB-0A86-45E5-B9F1-DB2A51BB375BQ33697388-72B30DC6-FA80-41BA-A7E2-1C1767E37A3DQ33785741-C20DD0D3-5294-4575-B70F-00B7A710C515Q33932159-6BDE2B9B-FE05-4ABF-BE4F-CDEBB7E2ABD0Q34312543-B618BA7E-8B78-49C1-A03C-6CA3E5F50320Q34518736-F431875E-8D68-41C2-86DD-348B9D121C89Q35054853-E96E1493-FC16-443B-BE8A-7AA9A3745983Q35612372-9D3F615B-B65D-4733-AE01-981DA57FE013Q35707150-73743B7E-3147-4C00-A0E7-87CFED1996B7Q36306351-A73025BE-A981-4B9C-96AC-005497827F09Q37110591-A6E01CAB-2DDB-46AC-938D-CEC5E1166118Q37461601-BBC32C07-AF65-40B8-BD4C-BC5FC9AB2F48Q37615803-68C31DB4-3943-4C47-A732-683C25995825Q37949588-DB30368E-F62E-45EA-A369-753F0330C0C9Q38010045-57C155C4-D47C-4655-A059-B62F6A33F0F4Q38053074-A5C6774F-227A-4243-985C-9F761D9E72D6Q38077692-544D1313-E19A-413E-92A5-2B754FF95698Q38162106-3728E233-E22A-47AD-A284-5ECD077FDBFFQ38174888-8008AF2E-B82E-4B15-B3E0-8E48DECE8835Q38530302-87AED214-378E-466F-A9ED-B33066F38EE7Q38622865-67C1F1C7-A29B-47A4-A848-36CB8B18A2B0Q38982409-07F096F8-4785-4446-9294-4FD0BFF6D523Q39408308-C0F0C288-FFC4-4B16-87DA-38DF4F20BF8CQ42869412-14C91116-5D3A-4B39-B8DE-D418E7CFC7F0Q43105865-7844053F-9D77-4B72-81D7-E38C40537040Q46004196-DF7DB699-456A-4559-8361-62505D8C41BDQ46812245-5BA3B2A3-7094-4D1D-AAC1-A4BBAE5A42AB
P2860
Change in histone H3 phosphorylation, MAP kinase p38, SIR 2 and p53 expression by resveratrol in preventing streptozotocin induced type I diabetic nephropathy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Change in histone H3 phosphory ...... d type I diabetic nephropathy.
@en
Change in histone H3 phosphory ...... d type I diabetic nephropathy.
@nl
type
label
Change in histone H3 phosphory ...... d type I diabetic nephropathy.
@en
Change in histone H3 phosphory ...... d type I diabetic nephropathy.
@nl
prefLabel
Change in histone H3 phosphory ...... d type I diabetic nephropathy.
@en
Change in histone H3 phosphory ...... d type I diabetic nephropathy.
@nl
P2093
P2860
P1476
Change in histone H3 phosphory ...... d type I diabetic nephropathy.
@en
P2093
Anil Gaikwad
Dhiraj Kabra
Karmveer Singh
Kulbhushan Tikoo
Vikram Sharma
P2860
P304
P356
10.1080/10715760801998646
P577
2008-04-01T00:00:00Z